Australian Group on Antimicrobial Resistance (AGAR) surveillance outcome programs – bloodstream infections and antimicrobial resistance patterns in Australian children and adolescents, January 2022 – December 2023
Communicable Diseases Intelligence · 2025
DOI: 10.33321/cdi.2025.49.052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Communicable Diseases Intelligence, 2025. Verfasst von Anita Williams und 14 weiteren Autor:innen. Beteiligte Einrichtung: Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, Nedlands, WA; UWA Centre for Child Health Research, Sch…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, Drug Resistance, Bacterial. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Between January 2022 and December 2023, there were 1,827 bloodstream infection (BSI) isolates in 1,745 children and adolescents reported to the Australian Group on Antimicrobial Resistance (AGAR) surveillance outcome programs, with 40% of episodes in children aged < 12 months. Two-thirds of BSIs were community-onset. Of 1,034 gram-negative isolates, 932 (90%) were Enterobacterales. Gram-negative BSI episodes were more commonly community-onset and in children < 12 months of age. Of Enterobacterales isolates, 17.9% were ciprofloxacin resistant; 14.0% were ceftriaxone and/or ceftazidime resistant; 9.5% were gentamicin and/or tobramycin resistant; and 8.9% were piperacillin-tazobactam resistant. Increasing ciprofloxacin resistance was noted, primarily due to the increase in Salmonella Typhi BSI. Overall, 13% of Enterobacterales were extended spectrum β-lactamase producers, and 18.5% were multi-drug resistant (MDR). Of 601 Staphylococcus aureus isolates, 13.6% were methicillin-resistant (MRSA), and 5.5% were MDR. Overall, 14.4% of S. aureus isolates were erythromycin resistant; 10.3% were clindamycin resistant; and 5.0% were ciprofloxacin resistant. Erythromycin, clindamycin, and ciprofloxacin resistance in MRSA were significantly higher than in methicillin-sensitive isolates. No co-trimoxazole resistant S. aureus was isolated. There were 192 enterococcal isolates reported; 70.8% were E. faecalis and 17.2% were E faecium. All ampicillin-resistant, vancomycin-resistant, and MDR enterococci were E. faecium. The 2022–2023 AGAR Kids Biennial Report shows relative stability in the antimicrobial resistance landscape within the Australian paediatric population, with few significant differences detected when compared to the 2020–2021 report. Small increases in the proportion of resistant Enterobacterales and Enterococcus spp. isolates highlight the importance of ongoing surveillance to inform stewardship and infection prevention interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, Nedlands, WA; UWA Centre for Child Health Research, School of Medicine, University of Western Australia, Nedlands, WA. anita.…
- School of Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA; Department of Microbiology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Murdoch, WA; Australian Group on Antimicrobial Re…
- Australian Group on Antimicrobial Resistance, Adelaide, SA.
- Department of Microbiology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Murdoch, WA; Australian Group on Antimicrobial Resistance, Fiona Stanley Hospital, Murdoch, WA.
- School of Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA; Australian Group on Antimicrobial Resistance, Fiona Stanley Hospital, Murdoch, WA.
- Infectious Diseases, The Royal Children's Hospital Melbourne, Parkville, Victoria; Department of Paediatrics, University of Melbourne, Parkville, Victoria.
Zitieren
APA
Williams, A., Coombs, G., Bell, J., Daley, D., Mowlaboccus, S., Bryant, P., Campbell, A., Cooley, L., Howard-Jones, A., Iredell, J., Irwin, A., McMullan, B., Warner, M., Williams, P., & Blyth, C. (2025). Australian Group on Antimicrobial Resistance (AGAR) surveillance outcome programs – bloodstream infections and antimicrobial resistance patterns in Australian children and adolescents, January 2022 – December 2023. Communicable Diseases Intelligence. https://doi.org/10.33321/cdi.2025.49.052
Vancouver
Williams A, Coombs G, Bell J, Daley D, Mowlaboccus S, Bryant P, et al. Australian Group on Antimicrobial Resistance (AGAR) surveillance outcome programs – bloodstream infections and antimicrobial resistance patterns in Australian children and adolescents, January 2022 – December 2023. Communicable Diseases Intelligence. 2025. doi:10.33321/cdi.2025.49.052
BibTeX
@article{Williams2025,
author = {Williams, Anita and Coombs, Geoffrey and Bell, Jan and Daley, Denise and Mowlaboccus, Shakeel and Bryant, Penelope and Campbell, Anita and Cooley, Louise and Howard-Jones, Annaleise and Iredell, Jon and Irwin, Adam and McMullan, Brendan and Warner, Morgyn and Williams, Phoebe and Blyth, Christopher},
title = {Australian Group on Antimicrobial Resistance (AGAR) surveillance outcome programs – bloodstream infections and antimicrobial resistance patterns in Australian children and adolescents, January 2022 – December 2023},
journal = {Communicable Diseases Intelligence},
year = {2025},
doi = {10.33321/cdi.2025.49.052}
}
EUVIMED